Swab sample india covid
A medical worker takes a swab sample of a Sports Authority of India (SAI) employee for a Reverse Transcription Polymerase Chain Reaction (RT-PCR) test at Jawaharlal Nehru Stadium in New Delhi on April 16, 2021. Image Credit: AFP

India government says it will supply around 17,000 MT of oxygen to states worst-hit by COVID-19

New Delhi: (Reuters) The Indian government said on Friday it will supply 17,092 MT of medical oxygen in a dozen states where the virus is surging, including Maharashtra and capital city of Delhi.

Prime Minister Narendra Modi asked state to source medical oxygen from industrial plants, as supplies across the country have fallen short of meeting a demand surge due to a record-increase in COVID-19 infections.

India extended a record daily run of new COVID-19 infections on Friday, spurred by hundreds of positive tests at a major religious gathering, as politicians pushed ahead with election rallies against advice they could worsen the outbreak.

India is battling a massive second wave of the coronavirus pandemic, with new restrictions imposed in Mumbai, New Delhi and other cities. There are also growing calls for officials to speed up the country’s vaccination programme as hospitals are swamped with patients.

Eighth record daily increase

The 217,353 new cases reported by the health ministry on Friday marked the eighth record daily increase in the last nine days and took total cases to nearly 14.3 million. India’s case count is second only to the United States, which has reported more than 31 million infections.

Deaths in India rose by 1,185 over the past 24 hours “ the highest single-day rise in seven months “ to reach a total of 174,308, the health ministry reported.

Experts have raised concerns about the spread of more contagious and deadlier variants of the disease, particularly given widespread participation in religious festivals and political rallies. A Lancet study this month estimated that India’s fatalities could double by June.

india covid patient oxygen
A patient suffering from the coronavirus disease (COVID-19) gets treatment at the casualty ward in Lok Nayak Jai Prakash (LNJP) hospital, amidst the spread of the disease in New Delhi, India April 15, 2021. Image Credit: Reuters

“The biggest fight we have is in the society ... Over a period of time, people have adopted a casual approach,” Health Minister Harsh Vardhan said at New Delhi’s All India Institute of Medical Sciences on Friday.

Several senior leaders and opposition lawmakers, including Prime Minister Narendra Modi and Congress’s Rahul Gandhi, have been holding large rallies for supporters amid elections in five regions, including West Bengal.

Visuals from the rallies have shown thousands of mask-less people crowded together and chanting slogans as they listen to speeches from politicians, in clear violation of social distancing and other COVID-19 norms.

Interior Minister Amit Shah was scheduled to hold public meetings and roadshows in West Bengal on Friday.

Religious gathering

Meanwhile, hundreds of people at a religious gathering in Haridwar in the north of the country tested positive for COVID-19 as tens of thousands of devout pilgrims jostled to take a holy dip in the Ganges.

The weeks-long “Kumbh Mela” festival, where ascetics bathe to wash away their sins, began earlier this month and officials have warned they expect cases to rise significantly. One local official called it a “super-spreader” event.

Vaccine programme

India has so far injected 115 million vaccine doses, the highest globally after the United States and China, but that covers only a small fraction of its 1.4 billion people.

In the heat of the latest wave of infections, India has shifted from being a mass vaccine exporter to a major importer.

Officials abruptly changed the rules to allow vaccine imports to be fast-tracked, having earlier rebuffed foreign drugmakers like Pfizer. It will import Russia’s Sputnik V vaccine starting this month to cover as many as 125 million people.

India is also seeking to inoculate more of its population using domestically produced shots.

India on Thursday gave approval to the Haffkine Institute in the western Maharashtra state to begin producing Bharat Biotech’s COVAXIN shot, a move that is expected to help ease supply bottlenecks.

The country is currently administering COVAXIN and AstraZeneca’s vaccine, which is manufactured by the Serum Institute of India and branded Covishield.